Showing results (71-80 of 240) with videos related to
Sort By:
Pageof 24
BMJ (Clinical Research Ed.)|May 31, 2003
Pharmaceutical industry sponsorship and research outcome and quality: systematic reviewJoel Lexchin, Lisa A Bero, Benjamin Djulbegovic, et al.BMJ Open|January 8, 2017
Treatment targeted at underlying disease versus palliative care in terminally ill patients: a systematic reviewTea Reljic, Ambuj Kumar, Farina A Klocksieben, et al.BMC Medical Research Methodology|May 11, 2005
Use of re-randomized data in meta-analysisIztok Hozo, Benjamin Djulbegovic, Otavio Clark, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groupsAmbuj Kumar, Heloisa P Soares, Lodovico Balducci, et al.BMJ Open|September 30, 2016
When are clinical trials beneficial for study patients and future patients? A factorial vignette-based survey of institutional review board membersRahul Mhaskar, Branko Miladinovic, Thomas M Guterbock, et al.BMC Medical Informatics and Decision Making|December 27, 2011
Extensions to regret-based decision curve analysis: an application to hospice referral for terminal patientsAthanasios Tsalatsanis, Laura E Barnes, Iztok Hozo, et al.Journal of Evaluation in Clinical Practice|December 20, 2015
Towards theory integration: Threshold model as a link between signal detection theory, fast-and-frugal trees and evidence accumulation theoryIztok Hozo, Benjamin Djulbegovic, Shenghua Luan, et al.BMC Cancer|September 25, 2002
Erythropoietin, uncertainty principle and cancer related anaemiaOtavio Clark, Jared R Adams, Charles L Bennett, et al.Systematic Reviews|February 6, 2013
Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysisHesborn Wao, Rahul Mhaskar, Ambuj Kumar, et al.Contemporary Clinical Trials|January 1, 2013
Trial sequential analysis may be insufficient to draw firm conclusions regarding statistically significant treatment differences using observed intervention effects: a case study of meta-analyses of multiple myeloma trialsBranko Miladinovic, Ambuj Kumar, Iztok Hozo, et al.Pageof 24